Clinical Trial Update: Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) [Phase 3]

View source ↗

Summary

Phase 3 clinical study of droxidopa (NOH) completed; results posted in 2014 for patients with neurogenic orthostatic hypotension and related autonomic failure c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Failure
• Dopamine Beta-hydroxylase Deficiency
• Neurogenic Orthostatic Hypotension
• Non-diabetic Neuropathy

Drugs mentioned

• Droxidopa (Droxidopa)

Snippet

Sponsor: Chelsea Therapeutics | Conditions: Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2014-04-21